GlaxoSmithKline targets arthritis in first ResearchKit study by a drug company … https://t.co/xo2Ip6FP6s — The Propell Group (@ThePropellGroup) July 17, 2016 #healthtech
Hey Cultured Stylish thanks for following us. Check out https://t.co/sIofdGjy01 — The Propell Group (@ThePropellGroup) July 17, 2016 #healthtech
Hey Brian Cygan thanks for following us. Check out https://t.co/sIofdGjy01 — The Propell Group (@ThePropellGroup) July 16, 2016 #healthtech
Navigating the difficult road of medical device product development while avoiding the common pitfalls – https://t.co/bCFktkEtyZ — The Propell Group (@ThePropellGroup) July 16, 2016 #healthtech
Hey Technology thanks for following us. Check out https://t.co/sIofdGjy01 — The Propell Group (@ThePropellGroup) July 16, 2016 #healthtech
Light regulatory touch called appropriate for mobile health apps https://t.co/45Y0tgWDqG — The Propell Group (@ThePropellGroup) July 16, 2016 #healthtech
Economics of genomics: What will happen when hopes of genetic testing collide with the reality of insurance premiums https://t.co/uAz1FTZ5ED — The Propell Group (@ThePropellGroup) July 16, 2016 [...]
Am I cured, Doc? Blood test predicts if cancer will come back https://t.co/JOPmovK4Yi — The Propell Group (@ThePropellGroup) July 15, 2016 #healthtech
CMS fines, cuts off testing at Theranos, bans Holmes – MedCity NewsMedCity News https://t.co/n3jfi2hYj5 — The Propell Group (@ThePropellGroup) July 8, 2016 #healthtech
Well.pk, health ecommerce site, closes seed funding round of around US $1 million https://t.co/0N4UKIYyJc — The Propell Group (@ThePropellGroup) July 7, 2016 #healthtech